Show simple item record

dc.contributor.authorRichmond, RC
dc.contributor.authorAnderson, EL
dc.contributor.authorDashti, HS
dc.contributor.authorJones, SE
dc.contributor.authorLane, JM
dc.contributor.authorStrand, LB
dc.contributor.authorBrumpton, B
dc.contributor.authorRutter, MK
dc.contributor.authorWood, AR
dc.contributor.authorStraif, K
dc.contributor.authorRelton, CL
dc.contributor.authorMunafò, M
dc.contributor.authorFrayling, TM
dc.contributor.authorMartin, RM
dc.contributor.authorSaxena, R
dc.contributor.authorWeedon, MN
dc.contributor.authorLawlor, DA
dc.contributor.authorSmith, GD
dc.date.accessioned2019-11-04T14:06:39Z
dc.date.issued2019-06-26
dc.description.abstractObjective To examine whether sleep traits have a causal effect on risk of breast cancer. Design Mendelian randomisation study. Setting UK Biobank prospective cohort study and Breast Cancer Association Consortium (BCAC) case-control genome-wide association study. Participants 156 848 women in the multivariable regression and one sample mendelian randomisation (MR) analysis in UK Biobank (7784 with a breast cancer diagnosis) and 122 977 breast cancer cases and 105 974 controls from BCAC in the two sample MR analysis. Exposures Self reported chronotype (morning or evening preference), insomnia symptoms, and sleep duration in multivariable regression, and genetic variants robustly associated with these sleep traits. Main outcome measure Breast cancer diagnosis. Results In multivariable regression analysis using UK Biobank data on breast cancer incidence, morning preference was inversely associated with breast cancer (hazard ratio 0.95, 95% confidence interval 0.93 to 0.98 per category increase), whereas there was little evidence for an association between sleep duration and insomnia symptoms. Using 341 single nucleotide polymorphisms (SNPs) associated with chronotype, 91 SNPs associated with sleep duration, and 57 SNPs associated with insomnia symptoms, one sample MR analysis in UK Biobank provided some supportive evidence for a protective effect of morning preference on breast cancer risk (0.85, 0.70, 1.03 per category increase) but imprecise estimates for sleep duration and insomnia symptoms. Two sample MR using data from BCAC supported findings for a protective effect of morning preference (inverse variance weighted odds ratio 0.88, 95% confidence interval 0.82 to 0.93 per category increase) and adverse effect of increased sleep duration (1.19, 1.02 to 1.39 per hour increase) on breast cancer risk (both oestrogen receptor positive and oestrogen receptor negative), whereas evidence for insomnia symptoms was inconsistent. Results were largely robust to sensitivity analyses accounting for horizontal pleiotropy. Conclusions Findings showed consistent evidence for a protective effect of morning preference and suggestive evidence for an adverse effect of increased sleep duration on breast cancer risk.en_GB
dc.description.sponsorshipMedical Research Council (MRC)en_GB
dc.description.sponsorshipJonathan de Pass and Georgina de Passen_GB
dc.description.sponsorshipGovernment of Canada through Genome Canadaen_GB
dc.description.sponsorshipCanadian Institutes of Health Researchen_GB
dc.description.sponsorshipNational Institutes of Healthen_GB
dc.description.sponsorshipCancer Research UKen_GB
dc.description.sponsorshipEuropean Unionen_GB
dc.description.sponsorshipEconomic and Social Research Councilen_GB
dc.description.sponsorshipWellcomeen_GB
dc.identifier.citationVol. 365: l2327en_GB
dc.identifier.doi10.1136/bmj.l2327
dc.identifier.grantnumber16/72/18en_GB
dc.identifier.grantnumberPSR-SIIRI-701en_GB
dc.identifier.grantnumberU19 CA148065en_GB
dc.identifier.grantnumberX01HG007492en_GB
dc.identifier.grantnumberC1287/A10118en_GB
dc.identifier.grantnumberC1287/A16563en_GB
dc.identifier.grantnumberC1287/A10710en_GB
dc.identifier.grantnumberHEALTH-F2-2009-223175en_GB
dc.identifier.grantnumberH2020 633784en_GB
dc.identifier.grantnumber634935en_GB
dc.identifier.grantnumberMM_UU_00011/1en_GB
dc.identifier.grantnumberMC_UU_00011/2en_GB
dc.identifier.grantnumberMC_UU_00011/5en_GB
dc.identifier.grantnumberMC_UU_00011/6en_GB
dc.identifier.grantnumberMC_UU_00011/7en_GB
dc.identifier.grantnumberC18281/A19169en_GB
dc.identifier.grantnumberES/N000498/1en_GB
dc.identifier.grantnumberMR/M005070/1en_GB
dc.identifier.grantnumber323195:GLUCOSEGENES-FP7-IDEAS-ERCen_GB
dc.identifier.grantnumberWT097835MFen_GB
dc.identifier.urihttp://hdl.handle.net/10871/39498
dc.language.isoenen_GB
dc.publisherBMJ Publishing Groupen_GB
dc.rights© Published by the BMJ Publishing Group Limited 2019. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.en_GB
dc.titleInvestigating causal relations between sleep traits and risk of breast cancer in women: Mendelian randomisation studyen_GB
dc.typeArticleen_GB
dc.date.available2019-11-04T14:06:39Z
dc.identifier.issn0959-8146
dc.descriptionThis is the final version. Available from BMJ Publishing Group via the DOI in this record. en_GB
dc.identifier.journalBMJen_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2019-04-26
exeter.funder::Medical Research Council (MRC)en_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2019-04-26
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-11-04T13:57:16Z
refterms.versionFCDVoR
refterms.dateFOA2019-11-04T14:06:44Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Published by the BMJ Publishing Group Limited 2019. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © Published by the BMJ Publishing Group Limited 2019. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.